Skip to main content

Table 1 Summary of the twenty-three included studies

From: Prognostic effect of lncRNA SNHG7 on cancer outcome: a meta and bioinformatic analysis

 

Study

Origin of population

Study design

Disease

Number

Stage

SNHG7 assay

Survival analysis

Metastasis analysis

Hazard ratios

Follow-up Months

1

Chen 2018 [10]

China

R

Bladder cancer

92

I-III/IV

qRT-PCR

OS

LNM/DM

K-M

60

2

Cheng 2019 [25]

China

R

Pancreatic cancer

40

I-II/III-IV

qRT-PCR

OS

LNM

K-M

50

3

Chi 2018 [49]

China

R

Neuroblastoma

92

I-IIA/IIB-IV

qRT-PCR

OS

LNM

K-M

60

4

Hu 2019 [35]

China

R

Colorectal cancer

738

NA

TCGA database

OS

NA

K-M

14

5

Jia 2020 [36]

China

R

Neuroblastoma

45

I-II/III-IV

qRT-PCR

OS

NA

K-M

60

6

Jiang 2020 [37]

China

R

Breast cancer

57

I-II/III-IV

qRT-PCR

NA

LNM

NA

NA

7

Li 2018 [38]

China

R

Colorectal cancer

70

I-II/III-IV

qRT-PCR

OS/DFS

LNM/DM

K-M

60

8

Pang 2020 [39]

China

R

Non-small cell lung cancer

42

I-II/III-IV

qRT-PCR

NA

LNM

NA

NA

9

Qi 2018 [20]

China

R

Prostate cancer

42

II/III-IV

qRT-PCR

OS

LNM

K-M

60

10

Shan 2018 [24]

China

R

Colorectal cancer

48

I-II/III-IV

qRT-PCR

OS

LNM/DM

K-M

72

11

Shen 2020 [40]

China

R

Hepatocellular carcinoma

100

I-II/III-IV

qRT-PCR

OS/PFS

LNM

K-M

60

12

Wang 2019 [18]

China

R

Thyroid cancer

64

I-II/III-IV

qRT-PCR

NA

LNM

NA

NA

13

Wang 2020 [23, 27, 41]

China

R

Melanoma

80

I-II/III-IV

qRT-PCR

OS

LNM/DM

K-M

48

14

Wu 2019 [6]

China

R

Hypopharyngeal Cancer

73

I-II/III-IV

qRT-PCR

OS

LNM/DM

K-M

60

15

Wu 2020 [42]

China

R

Cervical Cancer

51

I-II/III-IV

qRT-PCR

OS

LNM

K-M

60

16

Xia 2019 [50]

China

R

Prostate cancer

127

I-II/III-IV

qRT-PCR

OS

LNM/DM

HR/K-M

60

17

Xie 2020 [43]

China

R

Hepatocellular carcinoma

80

NA

qRT-PCR

OS

NA

K-M

60

18

Yang 2019 [44]

China

R

Hepatocellular carcinoma

80

NA

qRT-PCR

OS

NA

K-M

60

19

Zeng 2019 [45]

China

R

Cervical cancer

60

I-II/III-IV

qRT-PCR

OS

LNM

HR/K-M

60

20

Zhang 2019 [7]

China

R

Gastric cancer

162

I-II/III-IV

qRT-PCR

OS

LNM/DM

K-M

96

21

Zhang 2020 [28, 46, 47]

China

R

Colorectal cancer

96

I/II-III

qRT-PCR

OS

LNM

K-M

40

22

Zhao 2020 [48]

China

R

Cervical cancer

45

I-II/III-IV

qRT-PCR

OS

LNM

K-M

50

23

Zhong 2018 [21]

China

R

Bladder cancer

134

I/II-IV

qRT-PCR

NA

LNM

NA

36

  1. BC breast cancer, BLC Bladder cancer, CC cervical cancer, CRC colorectal cancer, HCC hepatocellular carcinoma, GA gastric cancer, PC prostate cancer, PAC Pancreatic cancer, TC thyroid carcinoma, HC Hypopharyngeal Cancer, NSCLC Non-small cell lung cancer